US Edition
News from eastmud.com
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top eastmud.com News
Tokyo, Japan · TokyoTOKYO and CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen")) announced today that LEQEMBI® IQLIK™, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer's disease (AD) has been selected by TIME as one of the "Best Inventions…See the Story
LEQEMBI® IQLIK™(lecanemab-Irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" - Biogen (NASDAQ:BIIB)
49% Center coverage: 34 sources
InternationalPoland considers the bombing of the Nord Stream Baltic Sea pipeline a heroic act. The alleged and arrested Ukrainian accomplice Volodymyr Z., will likely not be extradited to Germany for geopolitical reasons.See the Story
Nord Stream attack: Polish PM against extradition to Germany
34% Center coverage: 3 sources
